GlaxoSmithKline PLC banner

GlaxoSmithKline PLC
OTC:GLAXF

Watchlist Manager
GlaxoSmithKline PLC Logo
GlaxoSmithKline PLC
OTC:GLAXF
Watchlist
Price: 26 USD 5.78%
Market Cap: $106.1B

Wall St Price Targets

GLAXF Price Targets Summary
GlaxoSmithKline PLC

Wall Street analysts forecast GLAXF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLAXF is 29.66 USD with a low forecast of 20.74 USD and a high forecast of 40.75 USD.

Lowest Forecast
Price Target
20.74 USD
20% Downside
Average Forecast
Price Target
29.66 USD
14% Upside
Highest Forecast
Price Target
40.75 USD
57% Upside
GlaxoSmithKline PLC Competitors:
Price Targets
CXT
Crane NXT Co
136% Upside
CCOI
Cogent Communications Holdings Inc
32% Upside

Revenue
Forecast

2% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
2% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.

Operating Income
Forecast

2% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
2% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 3%.

Net Income
Forecast

2% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss
2% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 4%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GLAXF's stock price target?
Price Target
29.66 USD

According to Wall Street analysts, the average 1-year price target for GLAXF is 29.66 USD with a low forecast of 20.74 USD and a high forecast of 40.75 USD.

What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.

What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 3%.

What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 4%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett